Serologix

12/01/2021

What is a virus 🦠 variant?

A variant arises as a mistake when the virus replicated itself. The more a virus spreads the more chance it has to mutate and become a new version of the same virus, also known as a variant. Mutations and variants are not necessarily more dangerous though. The World Health Organization (WHO) looks at the evidence and can classify coronavirus variants as either a variant of interest, or a variant of concern.

A variant of interest will have two things:
genetic changes predicted by scientists to cause problems, such as the virus spreading more quickly and causing more severe illness as well as significant community transmission, or multiple clusters in multiple countries.

When the WHO is even more worried about a variant, it gets classified as a variant of concern. A variant of concern is a variant also associated with at least one of the following things, not just in theory but in practice. Increased transmissibility, more severe disease and/or decreased effectiveness of public health measures, diagnosis, vaccines or treatments.

10/20/2021

Donors Needed!

Our company, Serologix, is currently looking for/compensating donors to participate in various research projects with the following conditions...

- ALS
- COVID Positive (diagnosed in the last 24 hours)
- Mononucleosis (diagnosed in the last 7-10 days)
- Lyme Disease (diagnosed in the last 30 days)
- Unvaccinated (had or didn't have COVID)
- Lupus
- Scleroderma
- Antiphospholipid syndrome
- Mixed connective tissue disease

If you or anyone you know meets this criteria, please contact me via my inbox so I can provide you with additional details. Thank you in advance for helping to save lives!

08/25/2021

COVID Vaccine Booster:

Pfizer and BioNTech say a third shot of their vaccine boosts antibodies against the virus, adding that said they will submit their data by the end of the week and ask the F.D.A. to approve a third shot. Johnson & Johnson also reported strong results for boosters of its single-dose vaccine and will submit the data to federal regulators.

The companies conducted a study of 306 volunteers who received a booster shot about five to eight months after their second shot. Researchers found that the level of antibodies that block the coronavirus jumped more than three times higher than the level after the second dose 💉

08/23/2021

Big news today!! The Has approved the Pfizer-BioNTech COVID-19 vaccine for ages 16 and older. It is the first COVID-19 vaccine in the U.S. to receive the approval. The vaccine continues to be available under emergency use authorization for those ages 12-15 as well as for the administration of a third dose in certain immunocompromised individuals.

✔

08/23/2021

https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine

FDA approved the first COVID-19 vaccine, now marketed as Comirnaty, for the prevention of COVID-19 disease in individuals 16 years of age and older.

08/17/2021

Plasma Donors Needed...

Our company, Serologix, is currently looking for/compensating donors with the following conditions. We are specifically looking for individuals who were recently diagnosed with Lyme Disease, Multiple Myeloma, Lupus or Chronic Hepatitis B. Should you qualify, each plasma donation is compensated at $350-$500.

If you or anyone you know meets this criteria, please contact me via my inbox so I can provide you with additional details. Thank you in advance for helping to save lives!

07/30/2021

It was both an honor and a privilege listening to Dr. Randall Hyer, the Senior Vice President of Moderna, speak yesterday regarding MRNA technology and the vaccine 💉

https://youtu.be/ydwoJm7KWF8

07/27/2021

The latest vaccine 💉 statistics from the

“As of July 26, 2021, more than 188.7 million people, or about 56.8% of the U.S. population, have received at least one dose of the vaccine. Of those, 163.2 million, or about half of the population, are fully vaccinated”

vaccines are safe and effective at preventing COVID-19, especially sever illness or death

06/12/2021

RESEARCH Project Donors Needed...

We are currently looking for/compensating donors to participate in blood/plasma donation in an effort to help research companies worldwide further develop testing, assays, vaccines, therapies and treatments for COVID-19 and other diseases.

We are currently looking for people with/who were:
(lab work/physicians diagnosis are required)

- COVID vaccine recipients (anyone scheduled to receive the vaccine)
- Recovered COVID donors with residual/long-term symptoms
- COVID donors (diagnosed in the past 24-48 hours)
- Smokers over 50
- People currently taking Gentamicin or Tobramycin
- Crohn's Disease
- Celiac Disease
- Endometriosis
- Scleroderma/Diffuse Systemic Sclerosis
- Cancer (active/in treatment)
- Type 1 Diabetes (a1c over 11%)
- Hypothyroidism/Hashimoto's Thyroiditis (high TSH, TPO, TG, T3 and/or T4)
- Graves Disease
- Lyme's Disease (recently diagnosed)
- Rheumatoid Arthritis (High RF factor)
- Hepatitis A and B (Acute)

These are paid research projects. If you or anyone you know meets this criteria, please contact me via my inbox or email me at kkierys@serologix.net so I can provide you with additional details. Thank you in advance for helping to save lives!

03/29/2021

Are you a smoker? If so, we currently have a project for you to participate in! We are looking for smokers, over the age of 50, to participate in a PAID research project.

If you, or anyone you know is interested, please message us or email kkierys@serologix.net